Corbus Pharmaceuticals Holdings Inc(NASDAQ : CRBP)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.53% | 87.99 | 1.3% | $894.47m | |
| AMGN | Amgen Inc. | 0.04% | 191.31 | 1.2% | $560.48m | |
| ONCE | Spark Therapeutics, Inc. | 0.33% | 113.96 | 11.2% | $458.43m | |
| GILD | Gilead Sciences, Inc. | -0.93% | 65.02 | 0.9% | $450.52m | |
| BIIB | Biogen Inc. | -1.28% | 325.65 | 1.3% | $354.96m | |
| BPTH | Bio-Path Holdings, Inc. | -5.48% | 27.79 | 190.1% | $296.94m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.66% | 407.60 | 2.6% | $280.72m | |
| ILMN | Illumina, Inc. | -1.31% | 305.78 | 3.5% | $269.47m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.32% | 187.48 | 1.9% | $245.27m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.20% | 126.82 | 15.4% | $210.77m | |
| EXAS | Exact Sciences Corporation | -3.44% | 91.93 | 25.3% | $194.56m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.90% | 133.51 | 2.0% | $181.24m | |
| A | Agilent Technologies, Inc. | -0.16% | 80.97 | 1.6% | $153.74m | |
| IONS | Ionis Pharmaceuticals, Inc. | 1.25% | 79.52 | 8.3% | $101.55m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.24% | 93.36 | 4.3% | $97.41m |
Company Profile
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded on December 18, 2013 and is headquartered in Norwood, MA.